Skip to main content
. 2022 Jul 1;132(13):e148826. doi: 10.1172/JCI148826

Figure 2. Maternal microchimerism across infancy is associated with HIV exposure, maternal and infant HLA class II compatibility, and infant sex.

Figure 2

Maternal microchimerism (MMc) expressed as microchimeric equivalents per infant genomic equivalents (gEq) assessed. ND, not detected; iHU, HIV-unexposed infants; iHEU, HIV-exposed, uninfected infants. Detection of MMc in infants at day 1, week 7, week 15, and week 36 of life by (A) HIV exposure, (C) maternal and infant HLA class II compatibility (score indicates the number of shared alleles from the mother’s perspective), and (E) infant sex. Level of MMc across infancy by (B) HIV exposure, (D) maternal and infant HLA compatibility, and (F) infant sex.